Gene · 56259
CTNNBL1: catenin beta like 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CTNNBL1: catenin beta like 1. Genes, record 56259. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/56259
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8WYA6 | Beta-catenin-like protein 1 | 563 | 9 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40313 | Q8WYA6 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7993 | Q8WYA6 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8101 | Q8WYA6 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8101 | Q8WYA6 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7993 | Q8WYA6 | Espacenet |
| EP 4487869 A2 | 2025-01-08 | 35 | Q8WYA6 | Espacenet |
| KR 1020240027895 A | 2024-03-04 | 232 | Q8WYA6 | Espacenet |
| JP 2023036863 A | 2023-03-14 | 232 | Q8WYA6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 12517 | Q8WYA6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 115488 | Q8WYA6 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants870
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CTNNBL1 papers | Newest fiscal year |
|---|---|---|---|
| P50CA136393 | Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer | 7 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 6 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 4 | 2025 |
| R01CA258239 | Novel multipronged Immunovirotherapy Approach for GBM Treatment | 3 | 2025 |
| ZIABC011078 | Phase 0-1 Clinical Trials | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 2 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 2 | 2025 |
| R01AG074570 | Chemical approaches to selectively target beta-rich amyloids | 2 | 2025 |
| R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 2 | 2025 |
1 to 10 of 870Source NIH's project files
See all 870 nih grantsPapers1,345
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impacts of carbon source type on metabolic pathways and microbial synergy in the simultaneous anammox and endogenous denitrification process. | Bioresour Technol | 2026 | 42542141 | PubTator, text mining | PubMed |
| GapR stiffens AT-rich and overtwisted DNA leading to differential effects on transcription based on gene context. | Nucleic Acids Res | 2026 | 42516079 | PubTator, text mining | PubMed |
| ADNP Functions During Early Brain Development and Their Relevance to ASD and ADNP Syndrome. | Int J Mol Sci | 2026 | 42450350 | PubTator, text mining | PubMed |
| Sulfur-driven adaptive succession of denitrifiers enables coordinated autotrophic-heterotrophic deep denitrification. | Water Res | 2026 | 42418980 | PubTator, text mining | PubMed |
| Active ROP2 triggers leaf senescence and orchestrates the growth-senescence trade-off under nitrogen starvation. | Plant Signal Behav | 2026 | 42287157 | PubTator, text mining | PubMed |
| Structure and function of periplasmic nitrate reductase. | Biochem Soc Trans | 2026 | 42206606 | PubTator, text mining | PubMed |
| NaP-TRAP: A versatile and accessible workflow to dissect principles of translational regulation and mRNA stability. | bioRxiv | 2026 | 42039511 | PubTator, text mining | PubMed |
| Unraveling the complexity of Helicobacter pylori: Virulence factors, biofilm formation, and antibiotic resistance. | J Physiol Pharmacol | 2026 | 41931732 | PubTator, text mining | PubMed |
| TSPY-like 2, Beyond the Histone Chaperone Role. | Biomolecules | 2026 | 41897314 | PubTator, text mining | PubMed |
| Ultrafast Electron Dynamics of a Ferrocene-Based Butadiyne-Bridged Complex. | J Phys Chem A | 2026 | 41838851 | PubTator, text mining | PubMed |
1 to 10 of 1,345
See all 1,345 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/56259
GET https://conductscience.org/api/genes/v1/56259/patents?page=2